Clinical Trials Directory

Trials / Completed

CompletedNCT05371717

Domiciliary Management of Dental Erosion in Patients With GERD With Biomimetic Hydroxyapatite

Management of Dental Erosion in Patients With Gastroesophageal Reflux Disease With Biomimetic Hydroxyapatite Toothpaste

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
University of Pavia · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to evaluate dental erosion in patients with gastroesophageal reflux disease (GERD). Patients consenting to participate to the study will undergo periodontal evaluation at the baseline. Then, professional dental hygiene will be performed. Patients will be randomly assigned to: * Trial group: home oral hygiene with Biorepair Total Protection + Biorepair Shock Treatment twice a day * Control group: home oral hygiene with Biorepair Total Protection Patients will be evaluated after 1, 3, 6, 9 and 12 months from baseline.

Detailed description

The aim of the present study is to evaluate dental erosion in patients with gastroesophageal reflux disease (GERD). Patients consenting to participate to the study will undergo periodontal evaluation at the baseline. Then, professional dental hygiene will be performed. Patients will be randomly assigned to: * Trial group: home oral hygiene with Biorepair Total Protection + Biorepair Shock Treatment twice a day * Control group: home oral hygiene with Biorepair Total Protection Patients will be evaluated after 1, 3, 6, 9 and 12 months from baseline.

Conditions

Interventions

TypeNameDescription
OTHERDomiciliary use of Biorepair Total Protection + Biorepair Shock TreatmentDomiciliary use of Biorepair Total Protection twice a day for oral hygiene + Biorepair Shock Treatment application for 10 min once a day.
OTHERBiorepair Total ProtectionDomiciliary use of Biorepair Total Protection twice a day for oral hygiene + Biorepair Shock Treatment application for 10 min once a day.

Timeline

Start date
2022-05-01
Primary completion
2024-09-17
Completion
2024-09-20
First posted
2022-05-12
Last updated
2024-10-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05371717. Inclusion in this directory is not an endorsement.